Tumor-associated high endothelial venules as therapeutic modulation targets in cancer immunotherapy
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · 2025-11 · 1880 (6) · 189500
DOI: 10.1016/j.bbcan.2025.189500 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2025-11. Verfasst von Jun-Ye Zhang und 4 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Oral & Maxillofacial Reconstruction and Regeneration, Key Laboratory of Oral Biomedicine Ministry of Education, Hubei Key Lab…. Hauptthemen laut MEDLINE: Neoplasms, Immunotherapy. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 133 Literaturangaben. Gefördert von: Fundamental Research Funds for the Central Universities, National Natural Science Foundation of China.
Abstract (Originalsprache)
Immunotherapy has shown remarkable efficacy in improving the prognosis and survival rates of cancer patients, yet the overall response rate remains relatively low. The discovery of high endothelial venules (HEVs) and tertiary lymphoid structures (TLSs) has brought new hope to antitumor immunity. HEVs, as specialized vascular structures, facilitate lymphocyte infiltration and enhance tumor immune responses, while TLSs provide an organized immune microenvironment that further supports antitumor immunity. Current studies often emphasize the immunoregulatory roles of HEVs or TLSs from relatively independent perspectives, overlooking the fact that the two constitute a temporospatially interactive and unified system. This review systematically explores the interdependence and interactions between tumor-associated high endothelial venules (TA-HEVs) and TLSs in terms of their development, organization, and function. From an integrative perspective, it highlights current pharmacological strategies aimed at inducing intratumoral HEVs and TLSs to enhance the efficacy of immunotherapy. Finally, the review discusses future perspectives on the potential molecular mechanisms underlying HEV formation, methodologies for HEV detection, and the development of precision-targeted therapies to modulate HEV/TLS formation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- State Key Laboratory of Oral & Maxillofacial Reconstruction and Regeneration, Key Laboratory of Oral Biomedicine Ministry of Education, Hubei Key Laboratory of Stomatology, School & Hospital of Stomatology, Frontier Sci…
Förderung
- Fundamental Research Funds for the Central Universities
- National Natural Science Foundation of China
Zitieren
APA
Zhang, J. Y., Piao, Z. Y., Su, G. L., Zhang, M. J., & Sun, Z. J. (2025). Tumor-associated high endothelial venules as therapeutic modulation targets in cancer immunotherapy. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, 1880(6), 189500. https://doi.org/10.1016/j.bbcan.2025.189500
Vancouver
Zhang JY, Piao ZY, Su GL, Zhang MJ, Sun ZJ. Tumor-associated high endothelial venules as therapeutic modulation targets in cancer immunotherapy. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 2025;1880(6):189500. doi:10.1016/j.bbcan.2025.189500
BibTeX
@article{Zhang2025,
author = {Zhang, Jun-Ye and Piao, Zhi-Yan and Su, Guang-Liang and Zhang, Meng-Jie and Sun, Zhi-Jun},
title = {Tumor-associated high endothelial venules as therapeutic modulation targets in cancer immunotherapy},
journal = {Biochimica et Biophysica Acta (BBA) - Reviews on Cancer},
year = {2025},
volume = {1880},
number = {6},
pages = {189500},
doi = {10.1016/j.bbcan.2025.189500}
}
EUVIMED